Peters Richard's most recent trade in Kineta Inc was a trade of 101,891 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kineta Inc | Richard Peters | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2025 | 101,891 | 0 | - | - | Common Stock | |
| Kineta Inc | Peters Richard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2025 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Peters Richard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2025 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Richard Peters | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2025 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Richard Peters | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 23 Jun 2025 | 12,500 | 100,597 | - | 0.6 | 7,638 | Common Stock |
| Kineta Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 6,000 | 101,891 | - | 0 | Common Stock | |
| Kineta Inc | Richard Peters | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.26 per share. | 23 Jun 2025 | 4,706 | 95,891 | - | 0.3 | 1,224 | Common Stock |
| Universal Insurance Holdin... | Richard D. Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 2,404 | 16,312 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 1,045 | 3,119 (0%) | 0% | 0 | Common Stock | |
| Kineta Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 2,074 (0%) | 0% | 0 | Common Stock | |
| Universal Insurance Holdin... | Richard D. Peterson | Director | Grant, award, or other acquisition of securities at price $ 18.62 per share. | 13 Jun 2024 | 3,491 | 13,908 (0%) | 0% | 18.6 | 65,002 | Common Stock |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 500 | 1,029 (0%) | 0% | 0 | Common Stock | |
| Universal Insurance Holdin... | Richard D. Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 4,005 | 10,417 (0%) | 0% | 0 | Common Stock | |
| Kineta Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Universal Insurance Holdin... | Richard D. Peterson | Director | Purchase of securities on an exchange or from another person at price $ 9.31 per share. | 29 Sep 2022 | 1,075 | 6,412 (0%) | 0% | 9.3 | 10,003 | Common Stock |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 10,605 (0%) | 0% | 0 | Common Stock | |
| Universal Insurance Holdin... | Richard D. Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,337 | 5,337 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 22,750 | 22,750 | - | - | Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Richard Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 4,610 | 4,610 (0%) | 0% | 0 | Common Stock |